University of Siena at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

University of Siena brings 2 presentations to ESGCT 2026 in Hamburg. Its work covers rare neurodevelopmental disorders modelled in patient-derived cells. One line studies how splicing goes wrong in Rett syndrome neurons, and another develops CRISPR gene correction for IQSEC2-related disorders, from patient recruitment through cellular models.

OrganizationESGCT 2026 Attendance
Poster
Wed Oct 28
1:30pm–3:30pm
Alternative splicing dysregulation in Rett Syndrome: modelling the MeCP2/PRPF40B interaction in patient-derived neurons
Disease Models
Rare and inherited disease
Poster
Wed Oct 28
1:30pm–3:30pm
CRISPR/Cas9-Based Gene Correction Strategy for IQSEC2-Related Neurodevelopmental Disorders: From Patient Recruitment to Cellular Disease Modeling
Gene Editing

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of Siena

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction